» Articles » PMID: 38404932

Proteomics and Its Current Application in Biomedical Area: Concise Review

Overview
Publisher Wiley
Specialty Biology
Date 2024 Feb 26
PMID 38404932
Authors
Affiliations
Soon will be listed here.
Abstract

Biomedical researchers tirelessly seek cutting-edge technologies to advance disease diagnosis, drug discovery, and therapeutic interventions, all aimed at enhancing human and animal well-being. Within this realm, proteomics stands out as a pivotal technology, focusing on extensive studies of protein composition, structure, function, and interactions. Proteomics, with its subdivisions of expression, structural, and functional proteomics, plays a crucial role in unraveling the complexities of biological systems. Various sophisticated techniques are employed in proteomics, including polyacrylamide gel electrophoresis, mass spectrometry analysis, NMR spectroscopy, protein microarray, X-ray crystallography, and Edman sequencing. These methods collectively contribute to the comprehensive understanding of proteins and their roles in health and disease. In the biomedical field, proteomics finds widespread application in cancer research and diagnosis, stem cell studies, and the diagnosis and research of both infectious and noninfectious diseases. In addition, it plays a pivotal role in drug discovery and the emerging frontier of personalized medicine. The versatility of proteomics allows researchers to delve into the intricacies of molecular mechanisms, paving the way for innovative therapeutic approaches. As infectious and noninfectious diseases continue to emerge and the field of biomedical research expands, the significance of proteomics becomes increasingly evident. Keeping abreast of the latest developments in proteomics applications becomes paramount for the development of therapeutics, translational research, and study of diverse diseases. This review aims to provide a comprehensive overview of proteomics, offering a concise outline of its current applications in the biomedical domain. By doing so, it seeks to contribute to the understanding and advancement of proteomics, emphasizing its pivotal role in shaping the future of biomedical research and therapeutic interventions.

Citing Articles

Relevance of proteomics and metabolomics approaches to overview the tumorigenesis and better management of cancer.

Singh P, Dhir Y, Gupta S, Kaushal A, Kala D, Nagraiik R 3 Biotech. 2025; 15(3):58.

PMID: 39949840 PMC: 11813842. DOI: 10.1007/s13205-025-04222-8.


Proteomic Signatures of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Narrative Review.

Dourdouna M, Tatsi E, Syriopoulou V, Michos A Children (Basel). 2024; 11(10).

PMID: 39457139 PMC: 11505985. DOI: 10.3390/children11101174.


Differential Protein Expression in Extracellular Vesicles Defines Treatment Responders and Non-Responders in Multiple Sclerosis.

Torres Iglesias G, Lopez-Molina M, Botella L, Laso-Garcia F, Chamorro B, Fernandez-Fournier M Int J Mol Sci. 2024; 25(19).

PMID: 39409091 PMC: 11477160. DOI: 10.3390/ijms251910761.


Few-shot meta-learning applied to whole brain activity maps improves systems neuropharmacology and drug discovery.

Luo X, Ding Y, Cao Y, Liu Z, Zhang W, Zeng S iScience. 2024; 27(10):110875.

PMID: 39319265 PMC: 11419810. DOI: 10.1016/j.isci.2024.110875.


Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia.

Mavridou D, Psatha K, Aivaliotis M J Pers Med. 2024; 14(8).

PMID: 39202022 PMC: 11355716. DOI: 10.3390/jpm14080831.


References
1.
Ummanni R, Mannsperger H, Sonntag J, Oswald M, Sharma A, Konig R . Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery. Biochim Biophys Acta. 2013; 1844(5):950-9. DOI: 10.1016/j.bbapap.2013.11.017. View

2.
Chen G, Pramanik B, Liu Y, Mirza U . Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery. J Mass Spectrom. 2007; 42(3):279-87. DOI: 10.1002/jms.1184. View

3.
Meng C, Jin X, Xia L, Shen S, Wang X, Cai J . Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats. J Proteome Res. 2009; 8(5):2463-75. DOI: 10.1021/pr801059u. View

4.
Gessel M, Norris J, Caprioli R . MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J Proteomics. 2014; 107:71-82. PMC: 4104210. DOI: 10.1016/j.jprot.2014.03.021. View

5.
Kotlo K, Johnson K, Grillon J, Geenen D, Pieter Detombe , Danziger R . Phosphoprotein abundance changes in hypertensive cardiac remodeling. J Proteomics. 2012; 77:1-13. PMC: 3581302. DOI: 10.1016/j.jprot.2012.05.041. View